389 related articles for article (PubMed ID: 38543112)
1. Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.
Danielpour D
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675493
[TBL] [Abstract][Full Text] [Related]
2. Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors.
Runa F; Ortiz-Soto G; de Barros NR; Kelber JA
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543112
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta signaling by Smad proteins.
Miyazono K; ten Dijke P; Heldin CH
Adv Immunol; 2000; 75():115-57. PubMed ID: 10879283
[TBL] [Abstract][Full Text] [Related]
4. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
[TBL] [Abstract][Full Text] [Related]
5. Difference of TGF-β/Smads signaling pathway in epithelial-mesenchymal transition of normal colonic epithelial cells induced by tumor-associated fibroblasts and colon cancer cells.
Wang XL; Huang C
Mol Biol Rep; 2019 Jun; 46(3):2749-2759. PubMed ID: 30835040
[TBL] [Abstract][Full Text] [Related]
6. Itch E3 ubiquitin ligase positively regulates TGF-β signaling to EMT via Smad7 ubiquitination.
Park SH; Jung EH; Kim GY; Kim BC; Lim JH; Woo CH
Mol Cells; 2015 Jan; 38(1):20-5. PubMed ID: 25518932
[TBL] [Abstract][Full Text] [Related]
7. Crossing Smads.
Wrana JL
Sci STKE; 2000 Mar; 2000(23):re1. PubMed ID: 11752591
[TBL] [Abstract][Full Text] [Related]
8. Effects and translatomics characteristics of a small-molecule inhibitor of METTL3 against non-small cell lung cancer.
Xiao H; Zhao R; Meng W; Liao Y
J Pharm Anal; 2023 Jun; 13(6):625-639. PubMed ID: 37440912
[TBL] [Abstract][Full Text] [Related]
9. Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.
Mota M; Sweha SR; Pun M; Natarajan SK; Ding Y; Chung C; Hawes D; Yang F; Judkins AR; Samajdar S; Cao X; Xiao L; Parolia A; Chinnaiyan AM; Venneti S
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2221175120. PubMed ID: 37094128
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer.
Sreekumar S; Zhou D; Mpoy C; Schenk E; Scott J; Arbeit JM; Xu J; Rogers BE
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834491
[TBL] [Abstract][Full Text] [Related]
11. Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric cancer.
Wang K; Yu Y; Wang W; Jiang Y; Li Y; Jiang X; Qiao Y; Chen L; Zhao X; Liu J; Yang A; Li J; Zhang R
Oncogene; 2023 Mar; 42(14):1072-1087. PubMed ID: 36774408
[TBL] [Abstract][Full Text] [Related]
12. Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats.
Tinsley HN; Mathew B; Chen X; Maxuitenko YY; Li N; Lowe WM; Whitt JD; Zhang W; Gary BD; Keeton AB; Grizzle WE; Grubbs CJ; Reynolds RC; Piazza GA
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765604
[TBL] [Abstract][Full Text] [Related]
13. JNK inhibitor IX restrains pancreatic cancer through p53 and p21.
Shi J; Yang X; Kang Q; Lu J; Denzinger M; Kornmann M; Traub B
Front Oncol; 2022; 12():1006131. PubMed ID: 36568248
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
